Smoking, body mass, and hot flashes in midlife women

Obstetrics and Gynecology

Volumn 101, Issue 2, 2003, Pages 264-272

  Whiteman, Maura K ^a,b   Staropoli, Catherine A ^a,b   Langenberg, Patricia W ^a,b   McCarter, Robert J ^a,b   Kjerulff, Kristen H ^a,b   Flaws, Jodi A ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b BALTIMORE VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BODY MASS; CLIMACTERIUM; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; HEALTH SURVEY; HOT FLUSH; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; PREMENOPAUSE; PRIORITY JOURNAL; RISK FACTOR; SMOKING; UNITED STATES;

ADULT; AGE FACTORS; BALTIMORE; BODY MASS INDEX; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HOT FLASHES; HUMANS; INCIDENCE; LIFE STYLE; LOGISTIC MODELS; MENOPAUSE; MIDDLE AGED; OBESITY; REFERENCE VALUES; RISK ASSESSMENT; RISK FACTORS; SAMPLING STUDIES; SEVERITY OF ILLNESS INDEX; SMOKING;

EID: 0037311509     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(02)02593-0     Document Type: Article

References (42)

1. Schwingl P.J., Hulka B.S., Harlow S.D. Risk factors for menopausal hot flashes. Obstet Gynecol. 84:1994;29-34.
2. Blumberg G., Kaplan B., Rabinerson D., Goldman G.A., Kitai E., Neri A. Women's attitudes towards menopause and hormone replacement therapy. Int J Gynaecol Obstet. 54:1996;271-277.
3. Oldenhave A., Jaszmann L.J., Haspels A.A., Everaerd W.T. Impact of climacteric on well-being. Am J Obstet Gynecol. 168:1993;772-780.
4. Birge S.J. Is there a role for estrogen replacement therapy in the prevention and treatment of dementia? J Am Geriatr Soc. 44:1996;865-870.
5. Lee S.J., Kanis J.A. An association between osteoporosis and premenstrual symptoms and postmenopausal symptoms. Bone Miner. 24:1994;127-134.
6. Avis N.E., Crawford S., Stellato R., Longcope C. Longitudinal study of hormone levels and depression among women transitioning through menopause. Climacteric. 4:2001;243-249.
7. Kuh D.L., Wadsworth M., Hardy R. Women's health in midlife The influence of the menopause, social factors and health in earlier life . Br J Obstet Gynaecol. 104:1997;923-933.
8. Staropoli C.A., Flaws J.A., Bush T.L., Moulton A.W. Predictors of menopausal hot flashes. J Womens Health. 7:1998;1149-1155.
9. Gold E.B., Sternfeld B., Kelsey J.L., Brown C., Mouton C., Reame N., et al. Relation to demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40-55 years of age. Am J Epidemiol. 152:2000;463-473.
10. Avis N.E., Crawford S.L., McKinlay S.M. Psychosocial, behavioral, and health factors related to menopause symptomatology. Womens Health. 3:1997;103-120.
11. Wilbur J., Miller A.M., Montgomery A., Chandler P. Sociodemographic characteristics, biological factors, and symptom reporting in midlife women. Menopause. 5:1998;43-51.
12. Freeman E.W., Sammel M.D., Grisso J.A., Battistini M., Garcia-Espagna B., Hollander L. Hot flashes in the late reproductive years Risk factors for African American and Caucasian women . J Womens Health Gend Based Med. 10:2001;67-76.
13. Leidy L.E., Canali C., Callahan W.E. The medicalization of menopause Implications for recruitment of study participants . Menopause. 7:2000;193-199.
14. Guthrie J.R., Dennerstein L., Hopper J.L., Burger H.G. Hot flushes, menstrual status, and hormone levels in a population-based sample of midlife women. Obstet Gynecol. 88:1996;437-442.
15. Cassidenti D.L., Vijod A.G., Vijod M.A., Stanczyk F.Z., Lobo R.A. Short-term effects of smoking on the pharmacokinetic profiles of micronized estradiol in postmenopausal women. Am J Obstet Gynecol. 163:1990;1953-1960.
16. Westhoff C., Gentile G., Lee J., Zacur H., Helbig D. Predictors of ovarian steroid secretion in reproductive-age women. Am J Epidemiol. 144:1996;381-388.
17. Michnovicz J.J., Hershcopf R.J., Naganuma H., Bradlow H.L., Fishman J. Increased 2-hydroxylation of estradiol as a possible mechanism for the anti-estrogenic effect of cigarette smoking. N Engl J Med. 315:1986;1305-1309.
18. Baron J.A., La Vecchia C., Levi F. The antiestrogenic effect of cigarette smoking in women. Am J Obstet Gynecol. 162:1990;502-514.
19. Jensen J., Christiansen C., Rodbro P. Cigarette smoking, serum estrogens, and bone loss during hormone-replacement therapy early after menopause. N Engl J Med. 313:1985;973-975.
20. Sharara F.I., Beatse S.N., Leonardi M.R., Navot D., Scott R.T. Jr. Cigarette smoking accelerates the development of diminished ovarian reserve as evidenced by the clomiphene citrate challenge test. Fertil Steril. 62:1994;257-262.
21. McKinlay S.M., Bifano N.L., McKinlay J.B. Smoking and age at menopause in women. Ann Intern Med. 103:1985;350-356.
22. Mattison D.R., Shiromizu K., Nightingale M.S. Oocyte destruction by polycyclic aromatic hydrocarbons. Am J Ind Med. 4:1983;191-202.
23. Takizawa K., Yagi H., Jerina D.M., Mattison D.R. Murine strain differences in ovotoxicity following intraovarian injection with benzo(a)pyrene, (+)-(7R,8S)-oxide, (-)-(7R,8R)-dihydrodiol, or (+)-(7R,8S)-diol-(9S,10R)-epoxide-2. Cancer Res. 44:1984;2571-2576.
24. Jull J.W., Phillips A.J. The effects of 7,12-dimethylbenz(a)anthracene on the ovarian response of mice and rats to gonadotrophins. Cancer Res. 29:1969;1977-1987.
25. Mattison D.R. The mechanisms of action of reproductive toxins. Am J Ind Med. 4:1983;65-79.
26. Bengtsson M., Rydstrom J. Regulation of carcinogen metabolism in the rat ovary by the estrous cycle and gonadotropin. Science. 219:1983;1437-1438.
27. Bengtsson M., Montelius J., Mankowitz L., Rydstrom J. Metabolism of polycyclic aromatic hydrocarbons in the rat ovary Comparison with metabolism in adrenal and liver tissues . Biochem Pharmacol. 32:1983;129-136.
28. Barbieri R.L., McShane P.M., Ryan K.J. Constituents of cigarette smoke inhibit human granulosa cell aromatase. Fertil Steril. 46:1986;232-236.
29. Shamsuddin A.K., Gan R. Immunocytochemical localizatin of benzo(a)pyrene-DNA adducts in human tissues. Hum Pathol. 19:1988;309-315.
30. Basler A., Rohrborn G. Chromosome aberrations in oocytes of NMRI mice and bone marrow cells of Chinese hamsters induced with 3,4-benzpyrene. Mutat Res. 38:1976;327-332.
31. Davidson G.E., Dawson G.W. The induction of somatic mutations in mouse embryos by benzo(a)pyrene. Arch Toxicol. 38:1977;99-103.
32. Longcope C., Johnston C.C. Jr. Androgen and estrogen dynamics in pre- and postmenopausal women A comparison between smokers and nonsmokers . J Clin Endocrinol Metab. 67:1988;379-383.
33. Brambilla D.J., McKinlay S.M. A prospective study of factors affecting age at menopause. J Clin Epidemiol. 42:1989;1031-1039.
34. Gold E.B., Bromberger J., Crawford S., Samuels S., Greendale G.A., Harlow S.D., et al. Factors associated with age at natural menopause in a multiethnic sample of midlife women. Am J Epidemiol. 153:2001;865-874.
35. Campagnoli C., Morra G., Belforte P., Belforte L., Prelato Tousijn L. Climacteric symptoms according to body weight in women of different socio-economic groups. Maturitas. 3:1981;279-287.
36. Erlik Y., Meldrum D.R., Judd H.L. Estrogen levels in postmenopausal women with hot flashes. Obstet Gynecol. 59:1982;403-407.
37. den Tonkelaar I., Seidell J.C., van Noord P.A. Obesity and fat distribution in relation to hot flashes in Dutch women from the DOM-project. Maturitas. 23:1996;301-305.
38. Klinga K., von Holst T., Runnebaum B. Influence of severe obesity on peripheral hormone concentrations in pre- and postmenopausal women. Eur J Obstet Gynecol Reprod Biol. 15:1983;103-112.
39. McKinlay S.M., Brambilla D.J., Posner J.G. The normal menopause transition. Maturitas. 14:1992;103-115.
40. Zachow R.J., Magoffin D.A. Direct intraovarian effects of leptin Impairment of the synergistic action of insulin-like growth factor-I on follicle-stimulating hormone-dependent estradiol-17β production by rat ovarian granulosa cells . Endocrinology. 138:1997;847-850.
41. Rice V.M., Limback S.D., Roby K.F., Terranova P.F. Tumor necrosis factor alpha inhibition of follicle-stimulating hormone-induced granulosa cell estradiol secretion in the human does not involve reduction of cAMP secretion but inhibition at post-cAMP site(s). Endocrine. 10:1999;19-23.
42. Luheshi G.N., Gardner J.D., Rushforth D.A., Loudon A.S., Rothwell N.J. Leptin actions on food intake and body temperature are mediated by IL-1. Proc Natl Acad Sci. 96:1999;7047-7052.